ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
勁方醫藥-B
31.800
+0.600
1.92%
手動刷新
成交量:
94.33萬
成交額:
3,021.21萬
市值:
113.53億
市盈率:
- -
高:
32.840
開:
30.800
低:
30.740
收:
31.200
52周最高:
50.200
52周最低:
28.780
股本:
3.57億
香港流通股本:
3.25億
量比:
0.69
換手率:
0.29%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
-30.27%
市淨率:
-3.94
市盈率(LYR):
- -
市銷率:
53.86
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
勁方醫藥-B(02595):悉數行使超額配股權、穩定價格期結束
智通财经
·
昨天
多隻醫藥新股上市頭日收漲超100%!包括曾申報科創板IPO未果的新股
制药网
·
昨天
勁方醫藥GFH375片啓動Ib/II期臨牀 適應症為晚期實體瘤
新浪财经
·
10/11
勁方醫藥-B10月10日遭主力拋售118.2萬元
市场透视
·
10/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02595"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"勁方醫藥-B","latestPrice":31.8,"timestamp":1760688489158,"preClose":31.2,"halted":0,"volume":943280,"delay":0,"floatShares":325000000,"shares":357000000,"eps":0,"marketStatus":"已收盤","change":0.6,"latestTime":"10-17 16:08:09","open":30.8,"high":32.84,"low":30.74,"amount":30212135,"amplitude":0.067308,"askPrice":31.8,"askSize":2000,"bidPrice":31.56,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1760923800000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":31.2,"openAndCloseTimeList":[[1760664600000,1760673600000],[1760677200000,1760688000000]],"volumeRatio":0.689861,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":325000000,"roa":"-30.27%","roe":"--","lyrEps":0,"volumeRatio":0.689861,"shares":357000000,"dividePrice":0,"high":32.84,"amplitude":0.067308,"preClose":31.2,"low":30.74,"week52Low":28.78,"pbRate":"-3.94","psRate":"53.86","week52High":50.2,"institutionHeld":0,"latestPrice":31.8,"eps":0,"divideRate":0,"volume":943280,"delay":0,"ttmEps":0,"open":30.8,"prevYearClose":20.39,"prevWeekClose":34.6,"prevMonthClose":40,"prevQuarterClose":40,"fiveDayClose":34.6,"twentyDayClose":20.39,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-10-16","current":-10.656974,"percent":0.882353,"low":-19.62221,"twenty":-19.014628,"median":-18.386711,"eighty":-11.753175,"high":-10.450758,"avg":-15.995786,"sd":3.600166,"marketCap":10774627656},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-16","current":-10.656974,"twenty":-19.014628,"median":-18.386711,"eighty":-11.753175,"marketCap":10774627656}],"updateTime":1760697384666},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575674517","title":"勁方醫藥-B(02595):悉數行使超額配股權、穩定價格期結束","url":"https://stock-news.laohu8.com/highlight/detail?id=2575674517","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575674517?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616345,"startTime":"0","endTime":"0","summary":"智通财经APP讯,劲方医药-B(02595)发布公告,独家保荐人兼整体协调人(为其本身及代表国际包销商)已于2025年10月16日悉数行使招股章程所述的超额配股权,涉及合共1338.6万股H股,占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股20.39港元发行及配发。超额配发股份将用于补足国际发售的超额分配。 此外,有关全球发售的稳定价格期已于2025年10月16日(即递交香港公开发售申请截止日期后第30日)结束。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","02595","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2575530714","title":"多隻醫藥新股上市頭日收漲超100%!包括曾申報科創板IPO未果的新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575530714","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575530714?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 16:58","pubTimestamp":1760605089,"startTime":"0","endTime":"0","summary":"银诺医药的暴涨更凸显了市场对核心创新资产的追捧。中国已成为全球第二大医药市场,其中创新药领域增长尤为迅猛。医药研发具有周期长、投入大、风险高的特点,一款新药从临床前研究到上市平均需投入 10 亿美元以上,成功率不足 10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02595","09939","BK1515","02575","00460","BK1574"],"gpt_icon":1},{"id":"2574517334","title":"勁方醫藥GFH375片啓動Ib/II期臨牀 適應症為晚期實體瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2574517334","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574517334?lang=zh_tw&edition=fundamental","pubTime":"2025-10-11 18:03","pubTimestamp":1760176980,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示,劲方医药科技(上海)有限公司的一项多中心、开放标签,探索GFH375联合西妥昔单抗或AG在实体瘤参与者中的安全性/耐受性、PK特征,探索联合用药疗效的Ib/II期临床研究已启动。该药物剂型为片剂,规格为100mg/片,用法为口服,按方案规定使用。GFH375片为化学药物,适应症为晚期实体瘤。晚期实体瘤指癌细胞已扩散至身体其他部位的肿瘤,症状因肿瘤类型而异,常见有疼痛、消瘦等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101119070594c3121b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101119070594c3121b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1574","BK1515","BK1161"],"gpt_icon":1},{"id":"2574487483","title":"勁方醫藥-B10月10日遭主力拋售118.2萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574487483","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574487483?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 16:15","pubTimestamp":1760084149,"startTime":"0","endTime":"0","summary":"10月10日, 劲方医药-B股价跌4.42%,报收34.60元,成交金额4217.3万元,换手率0.37%,振幅11.44%,量比1.21。劲方医药-B今日主力资金净流出118.2万元,上一交易日主力净流出863.7万元。该股近5个交易日下跌17.46%,主力资金累计净流出117.7万元;近20日主力资金累计净流出1941.5万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101016210697264c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101016210697264c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","02595","09939"],"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02595\",params:#limit:6,delay:false,,,undefined,":[]}}